Global expansion Solesis is expanding manufacturing capabilities with a new plant in Costa Rica, signaling opportunities to supply textile and polymer biomaterials for medical devices across North and Central America. Target regional distributors, contract manufacturers, and device OEMs in Central America and nearby regions.

Applied biomaterials focus With expertise in engineered textiles and polymer-based solutions for implantable devices and transfection-ready biomaterials, Solesis presents cross-selling potential to MedTech and Biopharma customers seeking advanced biomaterials, coatings, and transfection-ready components.

Strategic partnerships Recent collaboration announcements with Pluristyx for high-efficiency 3D transfection kits indicate openness to ecosystem partnerships. Identify co-development or OEM collaboration opportunities with iPSC and gene therapy platforms, as well as CROs and biotech accelerators.

Leadership and growth New leadership appointed in 2024 and a clear growth trajectory across five production facilities suggest a focus on scale, quality, and R&D. Leverage this for enterprise deals, long-term supply agreements, and manufacturing capacity commitments with large MedTech and Biopharma customers.

Financial and market readiness Revenue range and established U.S. footprint combined with Costa Rica expansion indicate readiness for multi-region contracts and compliance-ready solutions. Pursue multi-site manufacturing agreements, regulatory-competent supply chains, and value-based procurement conversations with potential larger buyers.